No More Specials

Premium

As the financial crisis came to a head toward the end of 2008, a bar near our office in New York's financial district offered recession specials — the more the Dow dropped, the cheaper the drinks. A few blocks away, outside the AIG building, a disgruntled man stood with a cut-out of the company's CEO and a handful of darts. Despite the levity some tried to bring to the situation, a general feeling of impending doom hung over lower Manhattan as the financial crisis deepened.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.